{"DataElement":{"publicId":"2840055","version":"1","preferredName":"Lung Tumor Pathologic Staging Category","preferredDefinition":"Classification of a lung malignancy or neoplasm into groups based on the extent of disease in the primary tumor, lymph nodes, and metastatic sites.","longName":"LUNG_PATH_STAG_CAT","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2230146","version":"1","preferredName":"Tumor Pathologic Stage Grouping","preferredDefinition":"information related to the pathologic stage grouping for a tumor.","longName":"TUM_PATH_STGRP","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2176931","version":"1","preferredName":"Tumor","preferredDefinition":"An abnormal tissue growth resulted from uncontrolled cell proliferation.  Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant ones exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia.  Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias. -- 2004","longName":"Tumor","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAAECCE-7B01-657B-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2230144","version":"1","preferredName":"Pathologic Stage Grouping","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)","longName":"C25610:C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F752037A-4CCE-36A8-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-05-18","modifiedBy":"ONEDATA","dateModified":"2005-05-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F752037A-4CD0-36A8-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-05-18","modifiedBy":"UMLLDR","dateModified":"2016-10-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2840044","version":"1","preferredName":"Lung Carcinoma Pathologic Staging Category","preferredDefinition":"An abnormal tissue growth resulted from uncontrolled cell proliferation._Caused by or altered by or manifesting disease or pathology._(STAY-jing) Performing exams and tests to learn the extent of the cancer within the body, especially whether the disease has spread from the original site to other parts of the body. It is important to know the stage of the disease in order to plan the best treatment._Category; used informally to mean a class of things._A carcinoma originating in the lung.  Lung carcinomas usually arise from the epithelium that lines the bronchial tree (bronchogenic carcinomas), and are classified as small cell or non-small cell carcinomas.  Non-small cell lung carcinomas are usually adenocarcinomas, squamous cell carcinomas, or large cell carcinomas.  Metastatic carcinomas to the lung are also common, and can be difficult to distinguish from primary tumors. -- 2004_Caused by or altered by or manifesting disease or pathology._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"LUNG_TUM_STAG_CAT","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IA","valueDescription":"Stage IA Lung Carcinoma","ValueMeaning":{"publicId":"2884068","version":"1","preferredName":"Stage IA Lung Carcinoma","longName":"2884068v1.00","preferredDefinition":"Stage IA includes: (T1a, N0, M0); (T1b, N0, M0).  T1a: Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a.  T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus).  N0: No regional lymph metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IA Lung Cancer AJCC v7","conceptCode":"C5642","definition":"Stage IA includes: (T1a, N0, M0); (T1b, N0, M0).  T1a: Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a.  T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus).  N0: No regional lymph metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A85E062-A84D-6D6D-E040-BB89AD4362EC","latestVersionIndicator":"Yes","beginDate":"2009-05-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-05-22","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A85E062-A866-6D6D-E040-BB89AD4362EC","beginDate":"2009-02-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-05-22","modifiedBy":"ONEDATA","dateModified":"2009-05-22","deletedIndicator":"No"},{"value":"IB","valueDescription":"Stage IB Lung Carcinoma","ValueMeaning":{"publicId":"2884070","version":"1","preferredName":"Stage IB Lung Carcinoma","longName":"2884070v1.00","preferredDefinition":"Stage IB includes: T2a, N0, M0.  T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension.  N0: No regional lymph metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IB Lung Cancer AJCC v7","conceptCode":"C5643","definition":"Stage IB includes: T2a, N0, M0.  T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension.  N0: No regional lymph metastasis.  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A85E062-A873-6D6D-E040-BB89AD4362EC","latestVersionIndicator":"Yes","beginDate":"2009-05-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-05-22","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A85E062-A88C-6D6D-E040-BB89AD4362EC","beginDate":"2009-02-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-05-22","modifiedBy":"ONEDATA","dateModified":"2009-05-22","deletedIndicator":"No"},{"value":"IIA","valueDescription":"Stage IIA Lung Carcinoma","ValueMeaning":{"publicId":"2884072","version":"1","preferredName":"Stage IIA Lung Carcinoma","longName":"2884072v1.00","preferredDefinition":"Stage IIA includes: (T2b, N0, M0); (T1a, N1, M0); (T1b, N1, M0); (T2a, N1, M0).  T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension.  T1a: Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a.  T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus).  T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension.  N0: No regional lymph node metastasis.  N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIA Lung Cancer AJCC v7","conceptCode":"C5644","definition":"Stage IIA includes: (T2b, N0, M0); (T1a, N1, M0); (T1b, N1, M0); (T2a, N1, M0).  T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension.  T1a: Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a.  T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus).  T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension.  N0: No regional lymph node metastasis.  N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A85E062-A899-6D6D-E040-BB89AD4362EC","latestVersionIndicator":"Yes","beginDate":"2009-05-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-05-22","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A85E062-A8B2-6D6D-E040-BB89AD4362EC","beginDate":"2009-02-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-05-22","modifiedBy":"ONEDATA","dateModified":"2009-05-22","deletedIndicator":"No"},{"value":"IIB","valueDescription":"Stage IIB Lung Carcinoma","ValueMeaning":{"publicId":"2884074","version":"1","preferredName":"Stage IIB Lung Carcinoma","longName":"2884074v1.00","preferredDefinition":"Stage IIB includes: (T2b, N1, M0); (T3, N0, M0).  T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension.  T3: Lung cancer with a tumor size more than 7 cm or one that directly invades any of the following: parietal pleural (PL3) chest wall (including superior sulcus tumors), diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium; or tumor in the main bronchus (less than 2 cm distal to the carina but without involvement of the carina); or associated atelectasis or obstructive pneumonitis of the entire lung or separate tumor nodule(s) in the same lobe. N0: No regional lymph node metastasis.  N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIB Lung Cancer AJCC v7","conceptCode":"C5645","definition":"Stage IIB includes: (T2b, N1, M0); (T3, N0, M0).  T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension.  T3: Lung cancer with a tumor size more than 7 cm or one that directly invades any of the following: parietal pleural (PL3) chest wall (including superior sulcus tumors), diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium; or tumor in the main bronchus (less than 2 cm distal to the carina but without involvement of the carina); or associated atelectasis or obstructive pneumonitis of the entire lung or separate tumor nodule(s) in the same lobe. N0: No regional lymph node metastasis.  N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A85E062-A8BF-6D6D-E040-BB89AD4362EC","latestVersionIndicator":"Yes","beginDate":"2009-05-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-05-22","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A85E062-A8D8-6D6D-E040-BB89AD4362EC","beginDate":"2009-02-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-05-22","modifiedBy":"ONEDATA","dateModified":"2009-05-22","deletedIndicator":"No"},{"value":"IIIA","valueDescription":"Stage IIIA Lung Carcinoma","ValueMeaning":{"publicId":"2884076","version":"1","preferredName":"Stage IIIA Lung Carcinoma","longName":"2884076v1.00","preferredDefinition":"Stage IIIA includes: (T1a, N2, M0); (T1b, N2, M0); (T2a, N2, M0); (T2b, N2, M0); (T3, N1, M0); (T3, N2, M0); (T4, N0, M0); (T4, N1, M0).  T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe.  N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension.  N2: Lung cancer with metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes.  M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIA Lung Cancer AJCC v7","conceptCode":"C5646","definition":"Stage IIIA includes: (T1a, N2, M0); (T1b, N2, M0); (T2a, N2, M0); (T2b, N2, M0); (T3, N1, M0); (T3, N2, M0); (T4, N0, M0); (T4, N1, M0).  T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe.  N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension.  N2: Lung cancer with metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes.  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A85E062-A8E5-6D6D-E040-BB89AD4362EC","latestVersionIndicator":"Yes","beginDate":"2009-05-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-05-22","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A85E062-A8FE-6D6D-E040-BB89AD4362EC","beginDate":"2009-02-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-05-22","modifiedBy":"ONEDATA","dateModified":"2009-05-22","deletedIndicator":"No"},{"value":"IIIB","valueDescription":"Stage IIIB Lung Carcinoma","ValueMeaning":{"publicId":"2884078","version":"1","preferredName":"Stage IIIB Lung Carcinoma","longName":"2884078v1.00","preferredDefinition":"Stage IIIB includes: (T1a, N3, M0); (T1b, N3, M0); (T2a, N3, M0); (T2b, N3, M0); (T3, N3, M0); (T4, N2, M0); (T4, N3, M0).  T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe.  N2: Lung cancer with metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes.  N3: Lung cancer with metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes.  M0: No distant metastasis. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIB Lung Cancer AJCC v7","conceptCode":"C5647","definition":"Stage IIIB includes: (T1a, N3, M0); (T1b, N3, M0); (T2a, N3, M0); (T2b, N3, M0); (T3, N3, M0); (T4, N2, M0); (T4, N3, M0).  T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe.  N2: Lung cancer with metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes.  N3: Lung cancer with metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes.  M0: No distant metastasis. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A85E062-A90B-6D6D-E040-BB89AD4362EC","latestVersionIndicator":"Yes","beginDate":"2009-05-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-05-22","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A85E062-A924-6D6D-E040-BB89AD4362EC","beginDate":"2009-02-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-05-22","modifiedBy":"ONEDATA","dateModified":"2009-05-22","deletedIndicator":"No"},{"value":"IV","valueDescription":"Stage IV Lung Cancer","ValueMeaning":{"publicId":"2884080","version":"1","preferredName":"Stage IV Lung Cancer","longName":"2884080","preferredDefinition":"Stage IV includes: Any T, Any N, M1.  M1: Distant metastasis present. (AJCC 6th ed.) - 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IV Lung Cancer AJCC v6","conceptCode":"C8774","definition":"Stage IV includes: Any T, Any N, M1.  M1: Distant metastasis present. (AJCC 6th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A85E062-A931-6D6D-E040-BB89AD4362EC","latestVersionIndicator":"Yes","beginDate":"2009-05-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-05-22","modifiedBy":"ONEDATA","dateModified":"2009-05-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A85E062-A94A-6D6D-E040-BB89AD4362EC","beginDate":"2009-02-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-05-22","modifiedBy":"ONEDATA","dateModified":"2009-05-22","deletedIndicator":"No"},{"value":"O","valueDescription":"Stage 0 Lung Cancer","ValueMeaning":{"publicId":"2884082","version":"1","preferredName":"Stage 0 Lung Cancer","longName":"2884082","preferredDefinition":"Stage 0 includes: Tis, N0, M0.  Tis: Carcinoma in situ.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th ed.) - 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage 0 Lung Cancer AJCC v6 and v7","conceptCode":"C27467","definition":"Stage 0 includes: Tis, N0, M0.  Tis: Carcinoma in situ.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6A85E062-A957-6D6D-E040-BB89AD4362EC","latestVersionIndicator":"Yes","beginDate":"2009-05-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-05-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6A85E062-A970-6D6D-E040-BB89AD4362EC","beginDate":"2009-02-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-05-22","modifiedBy":"ONEDATA","dateModified":"2009-05-22","deletedIndicator":"No"},{"value":"Occult Carcinoma","valueDescription":"Occult carcinoma","ValueMeaning":{"publicId":"2577319","version":"1","preferredName":"Occult carcinoma","longName":"2577319v1.00","preferredDefinition":"Occult lung cancer includes: TX, N0, M0. TX: Primary tumor cannot be assessed. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Occult Lung Cancer AJCC v8","conceptCode":"C136468","definition":"Occult lung cancer includes: TX, N0, M0. TX: Primary tumor cannot be assessed. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FB14-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-23","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-12-23","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"635CE127-F339-3FED-E040-BB89AD4375FF","beginDate":"2009-02-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-02-20","modifiedBy":"ONEDATA","dateModified":"2009-02-20","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2842798","version":"1","preferredName":"Lung Carcinoma Pathologic Staging Category","preferredDefinition":"A carcinoma originating in the lung.  Lung carcinomas usually arise from the epithelium that lines the bronchial tree (bronchogenic carcinomas), and are classified as small cell or non-small cell carcinomas.  Non-small cell lung carcinomas are usually adenocarcinomas, squamous cell carcinomas, or large cell carcinomas.  Metastatic carcinomas to the lung are also common, and can be difficult to distinguish from primary tumors. -- 2004:Pathologic; caused by or altered by or manifesting disease or pathology.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.:Category; used informally to mean a class of things.","longName":"C4878:C25610:C15608:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Carcinoma","conceptCode":"C4878","definition":"A carcinoma originating in the lung. Lung carcinomas usually arise from the epithelium that lines the bronchial tree (bronchogenic carcinomas), and are classified as small cell or non-small cell carcinomas. Non-small cell lung carcinomas are usually adenocarcinomas, squamous cell carcinomas, or large cell carcinomas. Metastatic carcinomas to the lung are also common, and can be difficult to distinguish from primary tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Staging","conceptCode":"C15608","definition":"The process of defining at what point in the natural history of a malignant disease a patient is when a diagnosis is made.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"642B8579-20A1-4C58-E040-BB89AD4304B1","latestVersionIndicator":"Yes","beginDate":"2009-03-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-03-02","modifiedBy":"ONEDATA","dateModified":"2009-03-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC:American Joint Committee on Cancer Cancer Staging Manual, 7th Ed., 2009","workflowStatus":"RELEASED","registrationStatus":"Application","id":"635CE127-F2B3-3FED-E040-BB89AD4375FF","latestVersionIndicator":"Yes","beginDate":"2009-02-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-02-20","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":"2023.8.28 Updated PV def for 'No Value Exists'. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2976812","version":"1","longName":"GO Trial","context":"SPOREs","ClassificationSchemeItems":[{"publicId":"2976834","version":"1","longName":"GO Trial","context":"SPOREs"}]},{"publicId":"5542681","version":"1","longName":"EDRN_CDE_Project","context":"EDRN","ClassificationSchemeItems":[{"publicId":"5543567","version":"1","longName":"Reused-CDEs","context":"EDRN"},{"publicId":"5542682","version":"1","longName":"Biospecimen CDEs","context":"EDRN"}]}],"AlternateNames":[{"name":"SPOREs","type":"USED_BY","context":"SPOREs"},{"name":"EDRN","type":"USED_BY","context":"EDRN"},{"name":"Reused-CDEs.Neoplasm.SPECIMEN_LUNG_STAGE-GROUP-PATH_CODE_791","type":"UML Qualified Attr","context":"EDRN"},{"name":"Neoplasm:SPECIMEN_LUNG_STAGE-GROUP-PATH_CODE_791","type":"UML Class:UML Attr","context":"EDRN"}],"ReferenceDocuments":[{"name":"Tumor Stage","type":"Preferred Question Text","description":"Tumor Stage","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"635DD6C7-5256-1187-E040-BB89AD4303B0","latestVersionIndicator":"Yes","beginDate":"2009-02-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-02-20","modifiedBy":"UMLLDR","dateModified":"2016-10-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}